Telithromycin Patent Expiration
Telithromycin is Used for treating respiratory infections caused by susceptible strains of designated microorganisms in adults over 18 years old. It was first introduced by Sanofi Aventis Us Llc
Telithromycin Patents
Given below is the list of patents protecting Telithromycin, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Ketek | US5635485 | Erythromycin compounds |
Apr 01, 2018
(Expired) | Sanofi Aventis Us |
| Ketek | USD459798 | Pill tablet |
Sep 24, 2015
(Expired) | Sanofi Aventis Us |
Telithromycin's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List